The Organ Transplant Center of West China Hospital, Sichuan University is a medical institution qualified to perform human organ transplants including liver, kidney, heart, lung, pancreas, and small intestine transplants, as recognized by the National Health Commission of China.

Liver Transplant

Leading Experts: Professor Yan Lunan, Professor Wu Hong, Professor Yang Jiayin
Team Members: Professor Yang Jian, Professor Lyu Tao, Professor Xie Kunlin, Professor Jin Shuguang
The team performed the first clinical liver transplant in Western China in the late 1970s. To date, it has completed over 800 clinical liver transplants using various surgical techniques, including more than 260 living donor liver transplants, with a surgical success rate of 100%.

Kidney Transplant  

Leading Experts: Professor Lin Tao, Associate Professor Wang Li
Team Members: Wang Xianding, Huang Zhongli, Song Turun
As one of the earliest institutions in China to perform kidney transplants, the team has conducted over 5,000 kidney transplant surgeries since completing the first case in September 1978. The number of living donor kidney transplants has ranked first in China for eight consecutive years.

Heart Transplant Leading Expert: Professor An Qi
Team Member: Wang Yabo
This is currently the only large-scale heart transplant center in Southwest China. The team completed the first adult heart transplant in 2005.

Lung Transplant  
Leading Experts: Professor Liu Lunxu, Professor Pu Qiang
As the earliest institution in Western China to perform lung transplants, the team successfully completed the first allogeneic sequential double lung transplant in Western China in 2007.

Pancreas Transplant
Professor Xu Mingqing
The team currently focuses on simultaneous pancreas-kidney transplantation for the treatment of diabetic renal failure. Six such procedures have been successfully completed, achieving remarkable clinical outcomes (ranking first in Sichuan Province in both volume and quality). All six surviving patients have well-functioning transplanted organs, have discontinued exogenous insulin and other glucose-lowering medications, and have shown significant improvement in diabetic retinopathy and neuropathy.

Corneal Transplant
Corneal transplantation in the Department of Ophthalmology at West China Hospital began in the 1960s and became well-established in the 1980s. The annual surgical volume has grown from 50–60 cases to over 200 cases currently. Surgical techniques have expanded from the initial single penetrating keratoplasty to include penetrating keratoplasty, lamellar keratoplasty, deep lamellar keratoplasty, bridge-bridge corneal transplantation, combined lamellar and penetrating keratoplasty, total lamellar keratoplasty with sclera, and ring-shaped corneal transplantation, among others. The volume and technical proficiency of corneal transplants rank among the top in China and lead in Western China. The head of the corneal transplant group, Professor Deng Yingping, serves as a member of the Standing Committee of the Ophthalmology Branch of the Chinese Medical Association and a member of the Corneal Disease Group. The team currently includes one professor, two associate professors, and one attending physician.

Small Intestine Transplant
Small intestine transplantation includes isolated small intestine transplantation, combined liver-small intestine transplantation, and abdominal multivisceral transplantation. Isolated small intestine transplantation is indicated for patients with intestinal failure, while combined liver-small intestine transplantation is required when liver failure develops due to parenteral nutrition. Combined liver-small intestine transplantation is primarily indicated for irreversible small intestine failure and liver failure caused by cholestasis resulting from long-term total parenteral nutrition. Multivisceral transplantation is indicated for irreversible failure of three or more abdominal organs (including the small intestine), extensive visceral vascular embolism, and cases where malignant tumors of the pancreas, duodenum, gastric antrum, bile duct, or gallbladder invade adjacent organs, or where primary liver cancer invades downward into adjacent organs. Compared with isolated small intestine transplantation, combined liver-small intestine transplantation reduces the incidence of both acute and chronic rejection. At present, combined liver-small intestine transplantation can be performed safely and successfully, with satisfactory long-term outcomes.